Narrow your search

Library

UGent (2)

KU Leuven (1)

Odisee (1)

Thomas More Kempen (1)

Thomas More Mechelen (1)

UCLL (1)

ULB (1)

ULiège (1)

VIVES (1)


Resource type

book (2)

dissertation (1)


Language

English (2)

German (1)


Year
From To Submit

2013 (1)

1977 (1)

1973 (1)

Listing 1 - 3 of 3
Sort by

Book
Durch Influenza-, Parainfluenza- und RS-Virus bedingte akute respiratorische Erkrankungen (ARE) und ihr Nachweis mit der Fluoreszenzantikörpertechnik (FAT) : Auswahlbibliographie
Author:
Year: 1977 Publisher: Jena : Universitätsbibliothek der Friedrich-Schiller-Universität Jena,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Dissertation
Studies on the immune response of the bovine respiratory tract to parainfluenza-3 virus
Authors: ---
Year: 1973 Publisher: Stockholm : Institute of Virology, Royal Veterinary College and National Veterinary Institute,


Book
Sendai Virus Vector : Advantages and Applications
Author:
ISBN: 4431545557 4431545565 Year: 2013 Publisher: Tokyo : Springer Japan : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Sendai virus (SeV) is not just a mouse pathogen but is evolving into a cutting-edge component of biotechnology. SeV reverse genetics originating from a pure academic need to settle long-held questions in the biology and pathogenicity of nonsegmented negative strand RNA viruses (Mononegavirales) is about to bear the impressive fruit of multipurpose cytoplasmic (non-integrating) RNA vectors. This book brings together in one source the SeV biology revealed by conventional approaches and reverse genetics, the methods to construct the first-generation SeV vector and to generate safer versions, and the applications in medical settings that have left or are about to leave the laboratory bench. The applications, which already are diverse and have high medical impact, include use as vaccine vectors against AIDS and respiratory virus infections, creation of BioKnife to resect malignant tumors, induction of “footprint (transgene) free” pluripotent stem cells, and gene therapy for peripheral arterial disease. These achievements—which are just a few of many examples—were attainable only after rigorously incorporating the rich knowledge of SeV biology that has accumulated during the several decades since the discovery of the virus. Application of SeV vector is certain to expand greatly because of its extremely high performance in transgene expression and its remarkable target cell breadth.

Listing 1 - 3 of 3
Sort by